{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:33:34Z","timestamp":1793781214352,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03651-4","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:46:19Z","timestamp":1759491979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort"],"prefix":"10.1007","volume":"16","author":[{"given":"Thuy Thi Thu","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat Tan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toan Bao","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Thanh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"3651_CR1","unstructured":"Asafo-Agyei KO, Samant H. Hepatocellular Carcinoma. Treasure Island (FL) ineligible companies: copyright \u00a9 2025. StatPearls Publishing LLC.; 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/32644603\/"},{"key":"3651_CR2","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"3651_CR3","unstructured":"Jacques F, Fr\u00e9d\u00e9ric ME et al. L,. Global Cancer Observatory: Cancer Today Lyon, France: International Agency for Research on Cancer; 2024 [Available from: https:\/\/gco.iarc.who.int\/today. Accessed [10 June 2025]."},{"issue":"5","key":"3651_CR4","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","volume":"127","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB. Hepatocellular carcinoma: recent trends in the united States. Gastroenterology. 2004;127(5):S27\u201334. https:\/\/doi.org\/10.1053\/j.gastro.2004.09.013.","journal-title":"Gastroenterology"},{"key":"3651_CR5","doi-asserted-by":"publisher","unstructured":"Le DC, Nguyen TM, Nguyen DH, et al. Survival outcome and prognostic factors among patients with hepatocellular carcinoma: A Hospital-Based study. Clin Med Insights Oncol. 2023;17. https:\/\/doi.org\/10.1177\/11795549231178171.","DOI":"10.1177\/11795549231178171"},{"key":"3651_CR6","doi-asserted-by":"publisher","unstructured":"Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6). https:\/\/doi.org\/10.1097\/HEP.0000000000000466.","DOI":"10.1097\/HEP.0000000000000466"},{"issue":"1","key":"3651_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal AG, Zhang E, Narasimman M, et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J Hepatol. 2022;77(1):128\u201339. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.023.","journal-title":"J Hepatol"},{"issue":"10","key":"3651_CR8","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/hep4.2045","volume":"6","author":"AG Singal","year":"2022","unstructured":"Singal AG, Haaland B, Parikh ND, et al. Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: results of a network meta-analysis. Hepatol Commun. 2022;6(10):2925\u201336. https:\/\/doi.org\/10.1002\/hep4.2045.","journal-title":"Hepatol Commun"},{"issue":"6","key":"3651_CR9","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha Fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: A Meta-analysis. Gastroenterology. 2018;154(6):1706\u2013e181. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.064.","journal-title":"Gastroenterology"},{"issue":"2","key":"3651_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3350\/cmh.2022.0212","volume":"29","author":"DY Kim","year":"2023","unstructured":"Kim DY, Toan BN, Tan CK, et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clin Mol Hepatol. 2023;29(2):277\u201392. https:\/\/doi.org\/10.3350\/cmh.2022.0212.","journal-title":"Clin Mol Hepatol"},{"issue":"17","key":"3651_CR11","doi-asserted-by":"publisher","first-page":"e3448","DOI":"10.1097\/md.0000000000003448","volume":"95","author":"J De","year":"2016","unstructured":"De J, Shen Y, Qin J, et al. A systematic review of Des-\u03b3-Carboxy prothrombin for the diagnosis of primary hepatocellular carcinoma. Med (Baltim). 2016;95(17):e3448. https:\/\/doi.org\/10.1097\/md.0000000000003448.","journal-title":"Med (Baltim)"},{"issue":"5","key":"3651_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jgh3.12720","volume":"6","author":"HLY Chan","year":"2022","unstructured":"Chan HLY, Vogel A, Berg T, et al. Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis. JGH Open. 2022;6(5):292\u2013300. https:\/\/doi.org\/10.1002\/jgh3.12720.","journal-title":"JGH Open"},{"key":"3651_CR13","doi-asserted-by":"publisher","unstructured":"Guan M-C, Zhang S-Y, Ding Q, et al. The performance of GALAD score for diagnosing hepatocellular carcinoma in patients with chronic liver diseases: A systematic review and Meta-Analysis. J Clin Med. 2023;12(3). https:\/\/doi.org\/10.3390\/jcm12030949.","DOI":"10.3390\/jcm12030949"},{"key":"3651_CR14","doi-asserted-by":"publisher","unstructured":"Piratvisuth T, Hou J, Tanwandee T, et al. Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies. Hepatol Commun. 2023;7(11). https:\/\/doi.org\/10.1097\/hc9.0000000000000317.","DOI":"10.1097\/hc9.0000000000000317"},{"issue":"4","key":"3651_CR15","doi-asserted-by":"publisher","first-page":"e230146","DOI":"10.57264\/cer-2023-0146","volume":"13","author":"Y Nan","year":"2024","unstructured":"Nan Y, Garay OU, Lu X, et al. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in china: a cost-effectiveness analysis. J Comp Eff Res. 2024;13(4):e230146. https:\/\/doi.org\/10.57264\/cer-2023-0146.","journal-title":"J Comp Eff Res"},{"issue":"1","key":"3651_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12876-024-03185-z","volume":"24","author":"C Liu","year":"2024","unstructured":"Liu C, Li Z, Zhang Z, et al. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study. BMC Gastroenterol. 2024;24(1):93. https:\/\/doi.org\/10.1186\/s12876-024-03185-z.","journal-title":"BMC Gastroenterol"},{"key":"3651_CR17","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Liang YB, Wang QB, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2024;15:1519999. https:\/\/doi.org\/10.3389\/fimmu.2024.1519999.","journal-title":"Front Immunol"},{"key":"3651_CR18","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/jhc.S462168","volume":"11","author":"YK Li","year":"2024","unstructured":"Li YK, Wu S, Wu YS, et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: A retrospective study. J Hepatocell Carcinoma. 2024;11:1389\u2013402. https:\/\/doi.org\/10.2147\/jhc.S462168.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"3651_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17998\/jlc.19.2.97","volume":"19","author":"SY Yim","year":"2019","unstructured":"Yim SY, Lee J-S. The genomic landscape and its clinical implications in hepatocellular carcinoma. J Liver Cancer. 2019;19(2):97\u2013107. https:\/\/doi.org\/10.17998\/jlc.19.2.97.","journal-title":"J Liver Cancer"},{"issue":"1","key":"3651_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4254\/wjh.v10.i1.116","volume":"10","author":"SH Nguyen-Dinh","year":"2018","unstructured":"Nguyen-Dinh SH, Do A, Pham TND, et al. High burden of hepatocellular carcinoma and viral hepatitis in Southern and central vietnam: experience of a large tertiary referral center, 2010 to 2016. World J Hepatol. 2018;10(1):116\u201323. https:\/\/doi.org\/10.4254\/wjh.v10.i1.116.","journal-title":"World J Hepatol"},{"key":"3651_CR21","unstructured":"(MoH) VsMoH. Guidelines for the diagnosis and treatment of hepatocellular carcinoma 2020 [Available from: https:\/\/kcb.vn\/phac-do\/quyet-dinh-so-3129-qd-byt-ngay-17-thang-07-nam-2020-ve-viec-.html"},{"issue":"1","key":"3651_CR22","doi-asserted-by":"publisher","first-page":"107327481986279","DOI":"10.1177\/1073274819862793","volume":"26","author":"VQ Le","year":"2019","unstructured":"Le VQ, Nguyen VH, Nguyen VH, et al. Epidemiological characteristics of advanced hepatocellular carcinoma in the Northern region of Vietnam. Cancer Control. 2019;26(1):1073274819862793. https:\/\/doi.org\/10.1177\/1073274819862793.","journal-title":"Cancer Control"},{"issue":"3","key":"3651_CR23","first-page":"199","volume":"2","author":"LT Ngoan","year":"2001","unstructured":"Ngoan LT, Yoshimura T. Liver cancer in Viet nam: risk estimates of viral infections and Dioxin exposure in the South and North populations. Asian Pac J Cancer Prev. 2001;2(3):199\u2013202. https:\/\/doi.org\/https:\/\/pubmed.ncbi.nlm.nih.gov\/12718631\/.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"3651_CR24","doi-asserted-by":"publisher","first-page":"e0228857","DOI":"10.1371\/journal.pone.0228857","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen G, Zhang P, et al. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE. 2020;15(2):e0228857. https:\/\/doi.org\/10.1371\/journal.pone.0228857.","journal-title":"PLoS ONE"},{"issue":"2","key":"3651_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216\u201329. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3651_CR26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1515\/cclm.2007.262","volume":"45","author":"R Saffroy","year":"2007","unstructured":"Saffroy R, Pham P, Reffas M, et al. New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clin Chem Lab Med. 2007;45(9):1169\u201379. https:\/\/doi.org\/10.1515\/cclm.2007.262.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3651_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.1840110321","volume":"11","author":"SL Tsai","year":"1990","unstructured":"Tsai SL, Huang GT, Yang PM, et al. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology. 1990;11(3):481\u20138. https:\/\/doi.org\/10.1002\/hep.1840110321.","journal-title":"Hepatology"},{"issue":"1","key":"3651_CR28","first-page":"9","volume":"25","author":"F Brunello","year":"1993","unstructured":"Brunello F, Marcarino C, Pasquero P, et al. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma. Ital J Gastroenterol. 1993;25(1):9\u201312.","journal-title":"Ital J Gastroenterol"},{"issue":"2","key":"3651_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"B Sangro","year":"2025","unstructured":"Sangro B, Argemi J, Ronot M, et al. EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82(2):315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028.","journal-title":"J Hepatol"},{"key":"3651_CR30","doi-asserted-by":"publisher","unstructured":"Hou J, Berg T, Vogel A, et al. Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies. JHEP Rep. 2025;7(2). https:\/\/doi.org\/10.1016\/j.jhepr.2024.101263.","DOI":"10.1016\/j.jhepr.2024.101263"},{"issue":"1","key":"3651_CR31","doi-asserted-by":"publisher","first-page":"28996","DOI":"10.1038\/s41598-024-80257-w","volume":"14","author":"HLY Chan","year":"2024","unstructured":"Chan HLY, Hu Y, Malinowsky K, et al. Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection. Sci Rep. 2024;14(1):28996. https:\/\/doi.org\/10.1038\/s41598-024-80257-w.","journal-title":"Sci Rep"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03651-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:46:22Z","timestamp":1759491982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03651-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1813"}}